Auriga USA

Auriga Downgrades Myriad Genetics To Hold, Lowers PT To $25

Auriga Lowers PT On NetLogic To $36

Auriga Lowers PT On Juniper Networks To $40

Auriga Lowers PT On NetLogic To $36

Auriga Lowers PT On Juniper Networks To $40

Auriga Lowers PT On Hanwha SolarOne to $10

Auriga Maintains Rating, PT On CODE Following Earnings Report

Auriga Lowers PT On Hanwha SolarOne to $10

Auriga Maintains Rating, PT On CODE Following Earnings Report

Auriga Maintains Rating, PT On SPWRA

Auriga Raises PT On CAVM To $56

Auriga USA Recent News

Auriga Lowers PT On SOL To $15

Auriga Assumes Coverage Of UTHR

Auriga Upgrades Illumina To Buy, $75 PT

NetEase.com Benefitting From China's Growing Economy, PT Raised To $55 By Auriga

Auriga USA Downgrades Thoratec Corporation

Auriga USA Initiates Coverage On STR Holdings

Solarfun Power Downgraded To Hold

Auriga USA Reiterates Buy Rating On PCS, OMCL

Auriga Reports on Solar Power Application Data

Auriga Reiterates “Buy” Rating and $15 Price Target for JDSU

Auriga Upgrades ADCT to “Buy”

Auriga Upgrades ADCT to “Buy”

Top 5 Mid-Cap NASDAQ Stocks In The Services Sector With The Highest PEG Ratio (UAUA, GAME, APOL, EDMC, ROST)

RAX Is Well Positioned For Fundamental Upside

UTHR Best Biotech Stock For 2010

S’s Prepaid Offering Unlikely To Cannibalize Its Postpaid Users

Auriga Says Continue To Hold Allscripts

VTIV Acquires Privately-Held ParagonRx

Clarity Needed On Adtran: Hold, Tells Auriga (ADTN, T, VZ)

NWY Beats Market Volatility with Flexible Promotions

MU Poised to Confront DRAM Price Cuts